Ubiquitination during infection with Mouse Adenovirus
小鼠腺病毒感染过程中的泛素化
基本信息
- 批准号:10364682
- 负责人:
- 金额:$ 26.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-04 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:Adenovirus InfectionsAdenovirusesAutomobile DrivingCell physiologyCellsComplexCullin ProteinsDNADNA DamageDNA VirusesDataGeneticGoalsHost DefenseHumanInfectionInnate Immune ResponseIntegration Host FactorsInterferonsLATS1 geneLeadLigaseMediatingModelingMolecularMouse ProteinMusNuclearNucleic AcidsOrthologous GenePathway interactionsProcessProductionProteinsProteomeProteomicsRNAReportingResourcesRoleSeminalSignal TransductionSpecies SpecificitySubstrate SpecificitySystemTimeUbiquitinUbiquitinationViralViral PathogenesisViral ProteinsVirusVirus DiseasesYWHAQ genearmbasecellular targetinginnate immune pathwaysinnate immune sensinginsightmembermulticatalytic endopeptidase complexmultidisciplinaryresponsesensorubiquitin ligaseubiquitin-protein ligase
项目摘要
PROJECT SUMMARY
Viruses exert an extensive network of dynamic interactions with host components to promote infection by
dismantling cellular intrinsic and innate defenses. A central arm of viral takeover of cellular processes relies on
viral exploitation of the cellular ubiquitin system to induce degradation of host factors. However, there is a gap
in our understanding of the molecular mechanisms by which ubiquitin is harnessed by viral proteins. Here we
propose a cross-species comparison of the human and mouse adenovirus systems to explore how viruses
subvert host defenses via ubiquitin. Human adenovirus 5 (HAd5) is a prominent nuclear-replicating DNA virus
that redirects cellular Cullin E3 ubiquitin ligase activity via complex formation with two viral early proteins
(E1B55K and E4orf6). We recently developed a proteomics approach to define host proteins ubiquitinated when
the HAd5 E1B55K/E4orf6 complex is expressed. By combining our ubiquitome analysis with whole cell
proteomics, we were able to define which substrates are ubiquitinated and which are subsequently degraded as
a result of the E1B55K/E4orf6 complex. The strict species-specificity of adenovirus infection limits our ability to
study HAd in its natural host, but mouse adenovirus type 1 (MAV-1) provides an alternative tractable system.
Based on genetic similarities, MAV-1 is thought to encode orthologs (mE1B55K and mE4orf6) to the HAd5
complex, and these proteins are presumed to redirect cellular ubiquitin in a parallel fashion. We have applied
our proteomics pipeline to MAV-1 infected cells, and used global ubiquitin-profiling to identify proteins modified
and degraded by the virus. Distinct from HAd5, we discovered that MAV-1 uniquely facilitates degradation of
several canonical and non-canonical proteins involved in nucleic acid sensing and antiviral interferon signaling,
including PKR and STING. Contrary to the prevailing dogma of how the HAd5 E1B55K/E4orf6 complex employs
the E1B55K component to select ubiquitination substrates, we surprisingly discovered that mE4orf6 is sufficient
to reduce abundance of the antiviral RNA sensor PKR in a proteasome- and Cullin- dependent manner,
independent of mE1B55K. These findings collectively suggest divergence in the composition, mechanisms of
assembly, and substrate selectivity between the HAd5 and MAV-1 directed E3 ligases. An overarching
implication is that the MAV-1 and HAd5 complex exploit ubiquitin in different ways to counteract intrinsic and
innate immune responses. In Aim 1 we will leverage a multidisciplinary, quantitative proteomics approach to
systematically define the endogenous cellular ubiquitin substrates and associated pathways targeted during
MAV-1 infection. We will also determine the functional consequences of substrate ubiquitination during infection.
In Aim 2 we will establish the composition, and mechanisms of substrate selection for the MAV-1 directed E3
ligase complex and compare to HAd5. Results of our cross-species comparisons will provide insights into both
core principles and distinct strategies that govern how adenoviruses exploit cellular ubiquitin to dismantle host
defenses and facilitate viral pathogenesis.
项目概要
病毒与宿主成分发挥广泛的动态相互作用网络,通过以下方式促进感染:
拆除细胞内在和先天的防御。病毒接管细胞过程的中心臂依赖于
病毒利用细胞泛素系统诱导宿主因子降解。然而,还有一个差距
帮助我们了解病毒蛋白利用泛素的分子机制。在这里我们
提出对人类和小鼠腺病毒系统进行跨物种比较,以探索病毒如何
通过泛素破坏宿主防御。人类腺病毒 5 (HAd5) 是一种重要的核复制 DNA 病毒
通过与两种病毒早期蛋白形成复合物来重定向细胞 Cullin E3 泛素连接酶活性
(E1B55K 和 E4orf6)。我们最近开发了一种蛋白质组学方法来定义泛素化的宿主蛋白
表达 HAd5 E1B55K/E4orf6 复合物。通过将我们的泛素组分析与全细胞相结合
通过蛋白质组学,我们能够定义哪些底物被泛素化,哪些底物随后被降解为
E1B55K/E4orf6 复合体的结果。腺病毒感染的严格物种特异性限制了我们的能力
研究自然宿主中的 HAd,但小鼠 1 型腺病毒 (MAV-1) 提供了另一种易于处理的系统。
基于遗传相似性,MAV-1 被认为编码 HAd5 的直向同源物(mE1B55K 和 mE4orf6)
复杂,并且这些蛋白质被认为以平行的方式重定向细胞泛素。我们已经申请了
我们针对 MAV-1 感染细胞的蛋白质组学流程,并使用全局泛素分析来识别修饰的蛋白质
并被病毒降解。与 HAd5 不同,我们发现 MAV-1 独特地促进了
几种参与核酸传感和抗病毒干扰素信号传导的经典和非经典蛋白质,
包括 PKR 和 STING。与 HAd5 E1B55K/E4orf6 复合体如何使用的流行教条相反
E1B55K组件来选择泛素化底物,我们惊讶地发现mE4orf6就足够了
以蛋白酶体和 Cullin 依赖性方式减少抗病毒 RNA 传感器 PKR 的丰度,
独立于 mE1B55K。这些发现共同表明,其组成和机制存在差异。
HAd5 和 MAV-1 定向 E3 连接酶之间的组装和底物选择性。一个总体的
这意味着 MAV-1 和 HAd5 复合物以不同的方式利用泛素来抵消内在和
先天免疫反应。在目标 1 中,我们将利用多学科、定量蛋白质组学方法
系统地定义了内源性细胞泛素底物和相关的靶向途径
MAV-1 感染。我们还将确定感染期间底物泛素化的功能后果。
在目标 2 中,我们将建立 MAV-1 定向 E3 的组成和底物选择机制
连接酶复合物并与 HAd5 进行比较。我们的跨物种比较结果将提供对两者的见解
控制腺病毒如何利用细胞泛素来摧毁宿主的核心原则和独特策略
防御并促进病毒发病机制。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Adenovirus Remodeling of the Host Proteome and Host Factors Associated with Viral Genomes.
宿主蛋白质组的腺病毒重塑和与病毒基因组相关的宿主因子。
- DOI:
- 发表时间:2021-08-31
- 期刊:
- 影响因子:6.4
- 作者:Dybas, Joseph M;Lum, Krystal K;Kulej, Katarzyna;Reyes, Emigdio D;Lauman, Richard;Charman, Matthew;Purman, Caitlin E;Steinbock, Robert T;Grams, Nicholas;Price, Alexander M;Mendoza, Lydia;Garcia, Benjamin A;Weitzman, Matthew D
- 通讯作者:Weitzman, Matthew D
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew D. Weitzman其他文献
Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure.
腺病毒复制与 PML 核结构的动态特性相结合。
- DOI:
10.1101/gad.10.2.196 - 发表时间:
1996-01-15 - 期刊:
- 影响因子:10.5
- 作者:
Vassilis Doucas;A. M. Ishov;Anthony Romo;H. Juguilon;Matthew D. Weitzman;Ronald M. Evans;Gerd G. Maul - 通讯作者:
Gerd G. Maul
Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers
将野生型和重组腺相关病毒招募到腺病毒复制中心
- DOI:
- 发表时间:
1996 - 期刊:
- 影响因子:5.4
- 作者:
Matthew D. Weitzman;K. Fisher;James M. Wilson - 通讯作者:
James M. Wilson
SWAMNA: a comprehensive platform for analysis of nucleic acid modifications
- DOI:
10.1039/d3cc04402e - 发表时间:
2023-10 - 期刊:
- 影响因子:4.9
- 作者:
Yixuan Xie;Francisca N. De Luna Vitorino;Ye Chen;Joanna K. Lempiäinen;Chenfeng Zhao;Robert T. Steinbock;Zongtao Lin;Xingyu Liu;Emily Zahn;Arabella L. Garcia;Matthew D. Weitzman;Benjamin A. Garcia - 通讯作者:
Benjamin A. Garcia
The SMC5/6 complex prevents genotoxicity upon APOBEC3A-mediated replication stress
SMC5/6 复合物可防止 APOBEC3A 介导的复制应激引起的基因毒性
- DOI:
10.1101/2023.11.28.568952 - 发表时间:
2023-11-28 - 期刊:
- 影响因子:0
- 作者:
David R. O’Leary;A. R. Hansen;Dylan F. Fingerman;Thi Tran;Brooke R. Harris;Katharina E. Hayer;Jiayi Fan;Emily Chen;Mithila Tennakoon;Rachel A. DeWeerd;A. Meroni;Julia H. Szeto;Matthew D. Weitzman;Ophir Shalem;J. Bednarski;Aless;ro Vindigni;ro;Xiaolan Zhao;Abby M. Green - 通讯作者:
Abby M. Green
Virology under the Microscope—a Call for Rational Discourse
显微镜下的病毒学——呼吁理性话语
- DOI:
10.1128/msphere.00034-23 - 发表时间:
2023-04-20 - 期刊:
- 影响因子:4.8
- 作者:
F. Goodrum;Anice C. Lowen;S. Lakdawala;J. Alwine;A. Casadevall;M. Imperiale;W. Atwood;Daphne C. Avgousti;J. Baines;B. Banfield;L. Banks;Sumita Bhaduri;Deepta Bhattacharya;Daniel Blanco;David Bloom;A. Boon;S. Boulant;Curtis Brandt;A. Broadbent;C. Brooke;Craig Cameron;Samuel Campos;Patrizia Caposio;Gary C. Chan;Anna R. Cliffe;J. Coffin;K. Collins;B. Damania;Michael Daugherty;Kari Debbink;J. Decaprio;T. Dermody;J. Dikeakos;D. DiMaio;R. Dinglasan;W. Duprex;R. Dutch;N. Elde;M. Emerman;L. Enquist;B. Fane;A. Fernández;M. Flenniken;L. Frappier;M. Frieman;K. Frueh;Michaela U. Gack;M. Gaglia;Thomas M. Gallagher;D. Galloway;A. García;A. Geballe;B. Glaunsinger;Stephen Goff;A. Greninger;Meaghan H. Hancock;E. Harris;Nicholas S. Heaton;M. Heise;E. Heldwein;B. Hogue;Stacy M. Horner;E. Hutchinson;Joseph M. Hyser;W. Jackson;R. Kalejta;J. Kamil;Stephanie M. Karst;F. Kirchhoff;D. Knipe;T. Kowalik;M. Lagunoff;L. Laimins;R. Langlois;A. Lauring;Benhur Lee;D. Leib;Shan;R. Longnecker;C. Lopez;M. Luftig;Jennifer M. Lund;Balaji Manicassamy;G. McFadden;Michael McIntosh;Andrew Mehle;W. Miller;I. Mohr;Cary A. Moody;Nathaniel J. Moorman;A. Moscona;Bryan C. Mounce;Joshua C. Munger;K. Münger;Eain A. Murphy;M. Naghavi;Jay A. Nelson;C. Neufeldt;Janko Ž. Nikolich;C. O’Connor;Akira Ono;W. Orenstein;D. Ornelles;J. Ou;J. Parker;C. Parrish;A. Pekosz;P. Pellett;Julie K. Pfeiffer;Richard K. Plemper;S. Polyak;J. Purdy;D. Pyeon;M. Quiñones;R. Renne;Charles M. Rice;J. Schoggins;R. Roller;C. Russell;R. Sandri;M. Sapp;L. Schang;S. Schmid;S. Schultz‐Cherry;B. Semler;T. Shenk;G. Silvestri;V. Simon;Gregory Smith;Jason Smith;Katherine R Spindler;M. Stanifer;K. Subbarao;W. Sundquist;M. Suthar;T. Sutton;Andrew W. Tai;V. Tarakanova;B. tenOever;S. Tibbetts;S. Tompkins;Z. Toth;Koenraad van Doorslaer;M. Vignuzzi;N. Wallace;Derek Walsh;M. Weekes;J. Weinberg;Matthew D. Weitzman;S. Weller;S. Whelan;Elizabeth A. White;Bryan Williams;C. Wobus;S. Wong;A. Yurochko - 通讯作者:
A. Yurochko
Matthew D. Weitzman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew D. Weitzman', 18)}}的其他基金
Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
- 批准号:
10312411 - 财政年份:2021
- 资助金额:
$ 26.4万 - 项目类别:
Ubiquitination during infection with Mouse Adenovirus
小鼠腺病毒感染过程中的泛素化
- 批准号:
10152932 - 财政年份:2021
- 资助金额:
$ 26.4万 - 项目类别:
Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
- 批准号:
10448505 - 财政年份:2021
- 资助金额:
$ 26.4万 - 项目类别:
Double-stranded RNA during DNA virus infection
DNA病毒感染期间的双链RNA
- 批准号:
10571919 - 财政年份:2019
- 资助金额:
$ 26.4万 - 项目类别:
Double-stranded RNA during DNA virus infection
DNA病毒感染期间的双链RNA
- 批准号:
10092100 - 财政年份:2019
- 资助金额:
$ 26.4万 - 项目类别:
Double-stranded RNA during DNA virus infection
DNA病毒感染期间的双链RNA
- 批准号:
9886201 - 财政年份:2019
- 资助金额:
$ 26.4万 - 项目类别:
Double-stranded RNA during DNA virus infection
DNA病毒感染期间的双链RNA
- 批准号:
9764127 - 财政年份:2019
- 资助金额:
$ 26.4万 - 项目类别:
Double-stranded RNA during DNA virus infection
DNA病毒感染期间的双链RNA
- 批准号:
10359055 - 财政年份:2019
- 资助金额:
$ 26.4万 - 项目类别:
Adenovirus manipulation of cellular chromatin to overcome host responses
腺病毒操纵细胞染色质以克服宿主反应
- 批准号:
10238103 - 财政年份:2018
- 资助金额:
$ 26.4万 - 项目类别:
Adenovirus manipulation of cellular chromatin to overcome host responses
腺病毒操纵细胞染色质以克服宿主反应
- 批准号:
9790957 - 财政年份:2018
- 资助金额:
$ 26.4万 - 项目类别:
相似国自然基金
肝胆肿瘤治疗性溶瘤腺病毒疫苗的研制及其临床前应用性探索
- 批准号:82303776
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
禽腺病毒血清11型反向遗传平台的建立与毒株间致病性差异机制探究
- 批准号:32372997
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CD46和DSG2双受体在人B组腺病毒感染与致病中的协同作用和机制研究
- 批准号:32370155
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于sIgA的V(D)J结构多样性探索腺病毒载体鼻喷新冠奥密克戎疫苗诱导的呼吸道粘膜免疫原性特征
- 批准号:82302607
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PD-1/PD-L1信号促CD21-B细胞BCR髓外二次编辑降低自身反应性在儿童腺病毒肺炎中的作用机制研究
- 批准号:82370015
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Ubiquitination during infection with Mouse Adenovirus
小鼠腺病毒感染过程中的泛素化
- 批准号:
10152932 - 财政年份:2021
- 资助金额:
$ 26.4万 - 项目类别:
A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for Glioblastoma
一种新型腺病毒许可、免疫功能正常的仓鼠模型,用于评估胶质母细胞瘤的溶瘤腺病毒治疗
- 批准号:
10593081 - 财政年份:2020
- 资助金额:
$ 26.4万 - 项目类别:
A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for Glioblastoma
一种新型腺病毒许可、免疫功能正常的仓鼠模型,用于评估胶质母细胞瘤的溶瘤腺病毒治疗
- 批准号:
10593081 - 财政年份:2020
- 资助金额:
$ 26.4万 - 项目类别:
A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for Glioblastoma
一种新型腺病毒许可、免疫功能正常的仓鼠模型,用于评估胶质母细胞瘤的溶瘤腺病毒治疗
- 批准号:
10373942 - 财政年份:2020
- 资助金额:
$ 26.4万 - 项目类别: